Kaitlyn D’Onofrio

DocwireNews

A study evaluating trends in late mortality among five-year <a href="https://www.docwirenews.com/docwire-pick/home-page-picks/young-patients-doctors-sensitive-topics/">adolescent</a> and <a href="https://www.docwirenews.com/home-page-editor-picks/ecigarettes-marijuana-adolescents-youngadults/">young adult cancer survivors</a> found that survival rates are improving.&ldquo;Over the past several decades, treatment of cancer in adolescents and young adults (AYAs) has evolved substantially, leading to steady improvements in estimated five-year survival at diagnosis. However, the impact on late mortality in this population is largely unexamined,&rdquo; the researchers established.The study authors queried the Surveillance, Epidemiology, and End Results database for data on patients aged between 15 and 39 years who received a cancer diagnosis between 1975 and 2011 and survived for at least five years after their diagnosis; months of survival from five years post-diagnosis until death or the end of 2016 were accrued.The study was published in <a href="https://academic.oup.com/jnci/advance-article-abstract/doi/10.1093/jnci/djaa014/5739965?redirectedFrom=fulltext">JNCI: Journal of the National Cancer Institute</a>.<h2>Late Mortality Rates Declining, But Not Only Due to Primary Cancer</h2>Final analysis included 282,969 five-year adolescent and young adult cancer survivors. Five-year mortality in patients diagnosed between 1975 and 1984 was 8.3% (95% confidence interval [CI], 8.0% to 8.6%); this decreased to 5.4% (95% CI, 5.3% to 5.6%) for patients diagnosed between 2005 and 2011. The primary driver was decreases in mortality from the primary cancer, which decreased from 6.8% to 4.2% during the respective time periods, but this was not the case for some specific cancers&mdash;including colorectal, bone, sarcomas, cervical/uterine, and bladder&mdash;for which cumulative mortality curves presented only little improvement over the study period. In Hodgkin lymphoma, leukemia, kidney cancer, head and neck cancers, and trachea, lung, and bronchus cancers, late mortality due to noncancer/nonexternal causes was reduced.&ldquo;It is important that we monitor trends in survival not only among recently diagnosed patients, but also among survivors who are several years beyond their initial cancer diagnosis,&rdquo; said lead study author Chelsea Anderson, PhD, <a href="https://www.eurekalert.org/pub_releases/2020-03/oupu-csr022720.php">in a press release</a>. &ldquo;There have been substantial improvements over the past several decades for five-year survivors, though some cancer types have not shared in these improvements. Survivors of these cancer types may therefore be priority groups for efforts to improve long-term surveillance to reduce late mortality from cancer among adolescents and young adults.&rdquo;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Late Mortality Rates in Young Cancer Survivors Are Improving, According to Study

Oncology

A study evaluating trends in late mortality among five-year adolescent and young adult cancer survivors found that survival rates are improving. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe